查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
医疗器材报销市场 - 按付款人（公共、私人）、医疗机构（医院、门诊设施）和预测，2023 年至 2032 年
市场调查报告书
商品编码
1351517

医疗器材报销市场 - 按付款人（公共、私人）、医疗机构（医院、门诊设施）和预测，2023 年至 2032 年

Medical Devices Reimbursement Market - By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities) & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

在多个经济体有利的监管环境的推动下，2023 年至 2032 年间，全球医疗器材报销市场规模将以 7.3% 的复合年增长率扩大。监管环境显着影响医疗器材报销。政府机构，例如美国 FDA 和欧洲药品管理局 (EMA)，制定医疗器材的审批和报销途径。

法规的变化，包括审批流程、标籤要求和上市后监督，可以直接影响设备製造商的报销策略，从而促进市场的成长和发展。例如，法国卫生部的 Louisa Stuwe 表示，2023 年 7 月，法国用于远端患者监测和数位治疗的数位设备现在有资格获得快速存取和报销，这一过程与德国的 DiGA 计划相似。

整个医疗器材报销市场根据付款人、医疗保健环境和地区进行划分。

私人付款人从 2023 年到 2032 年的复合年增长率可能达到 7%，并由于能够提供更大的灵活性和客製化的核保选项，到 2032 年将主导医疗器材报销市场份额。与政府资助的计画通常有严格的法规和有限的预算不同，私人付款人可以快速适应新技术和疗法。这种适应性吸引了寻求全面覆盖的患者和寻求更快报销流程的设备製造商，推动了医疗设备报销领域中私人付款人参与的激增。

到 2032 年，医疗器材报销行业的门诊设施部分的复合年增长率可能会达到 7.9%。在门诊环境中提供先进的微创手术的趋势日益明显，这增加了对可报销医疗器材的需求。此外，门诊设施比医院更具成本效益，这使其成为对患者和付款人都有吸引力的选择。因此，对门诊护理的需求不断增长，推动了对医疗设备报销解决方案的需求，以支持这些不断发展的医疗保健服务模式。

欧洲医疗器材报销产业2023-2032年将呈现7%的成长率。医疗保健支出的增加、人口老化以及慢性病盛行率的增加正在推动对创新医疗技术的需求。欧洲各国政府也在改革报销政策，以方便取得尖端医疗设备。此外，数位健康解决方案的成长和对基于价值的护理模式的更加重视正在促进整个欧洲医疗器材报销行业的扩张。

目录

第 1 章：方法论

  • 行业覆盖
  • 市场范围和定义
  • 基本估算和工作
    • 数据采集
  • 预测参数
  • COVID-19 对全球的影响
  • 数据验证
  • 资料来源
    • 基本的
    • 中学
      • 付费来源
      • 无偿来源

第 2 章：执行摘要

第 3 章：医疗器材报销产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 各种慢性病盛行率不断上升
      • 人口老化加剧
      • 医疗费用负担日益加重
      • 支持性政府计划
    • 产业陷阱与挑战
      • 复杂的框架
      • 有限的承保范围和报销设施
  • 成长潜力分析
    • 按付款人
    • 按医疗保健环境
  • COVID-19 影响分析
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 政策倡议
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局，2022 年

  • 介绍
  • 2022 年公司矩阵分析
  • 竞争定位矩阵
  • 供应商矩阵分析
  • 2022 年公司市占率分析
  • 策略仪表板，2022 年

第 5 章：医疗器材报销市场规模与预测：按付款人

  • 主要付款人趋势
  • 民众
  • 私人的

第 6 章：医疗器材报销市场规模与预测：按医疗保健环境

  • 主要医疗保健环境趋势
  • 医院
  • 门诊设施
  • 其他的

第 7 章：医疗器材报销市场规模及预测：按地区

  • 主要区域趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 瑞典
    • 荷兰人
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 印尼
    • 菲律宾
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
  • MEA
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 土耳其
    • 以色列
    • 伊朗

第 8 章：公司简介

  • CVS Health
  • BNP Paribas
  • Aviva
  • Cigna
  • United Health Group
  • Allianz
  • Aetna
  • Humana Inc.
  • WellCare Health Plans, Inc.
  • Nippon Life Insurance Company
  • Anthem Insurance Companies, Inc.
Product Code: 6175

Global Medical Devices Reimbursement Market size will expand at 7.3% CAGR between 2023 and 2032, driven by the favorable regulatory environment across several economies. The regulatory landscape significantly impacts medical device reimbursement. Government agencies, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, establish the approval and reimbursement pathways for medical devices.

Changes in regulations, including the approval process, labeling requirements, and post-market surveillance, can directly impact reimbursement strategies for device manufacturers, leading to market growth and development. For instance, in July 2023, digital devices for remote patient monitoring and digital therapeutics in France are now eligible for expedited access and reimbursement, a process that bears similarities to Germany's DiGA program, as stated by Louisa Stuwe from the French Ministry of Health.

The overall medical devices reimbursement market is segregated based on payer, healthcare setting, and region.

Private payers could register a 7% CAGR from 2023 to 2032 and dominate the medical devices reimbursement market share by 2032 due to their ability to offer more flexibility and customized coverage options. Unlike government-funded programs that often have stringent regulations and limited budgets, private payers can adapt quickly to new technologies and therapies. This adaptability attracts both patients seeking comprehensive coverage and device manufacturers looking for faster reimbursement processes, driving the surge in private payer participation within the medical device reimbursement landscape.

The outpatient facilities segment of the medical devices reimbursement industry could expand at 7.9% CAGR through 2032. There is a growing trend toward providing advanced, minimally invasive procedures in outpatient settings, increasing the need for reimbursable medical devices. Additionally, outpatient facilities are more cost-effective than hospitals, making them an attractive option for both patients and payers. As a result, the increasing demand for outpatient care is fueling the need for medical device reimbursement solutions to support these evolving healthcare delivery models.

Europe medical device reimbursement industry will exhibit a 7% growth rate throughout 2023-2032. Rising healthcare expenditures, an aging population, and the increasing prevalence of chronic diseases are driving demand for innovative medical technologies. European governments are also reforming reimbursement policies to facilitate access to cutting-edge medical devices. Furthermore, the growth of digital health solutions and greater emphasis on value-based care models are contributing to the expansion of the medical device reimbursement sector across Europe.

Table of Contents

Chapter 1 Methodology

  • 1.1 Industry coverage
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 Data collection
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Payer trends
    • 2.1.4 Healthcare setting trends

Chapter 3 Medical Devices Reimbursement Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of various chronic diseases
      • 3.2.1.2 Rising aging population
      • 3.2.1.3 Growing burden of healthcare cost
      • 3.2.1.4 Supportive government programs
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Complex framework
      • 3.2.2.2 Limited coverage and reimbursement facilities
  • 3.3 Growth potential analysis
    • 3.3.1 By payer
    • 3.3.2 By healthcare setting
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
    • 3.5.4 Latin America
    • 3.5.5 MEA
  • 3.6 Technology landscape
  • 3.7 Future market trends
  • 3.8 Policy initiatives
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix
  • 4.4 Vendor matrix analysis
  • 4.5 Company market share analysis, 2022
  • 4.6 Strategy dashboard, 2022

Chapter 5 Medical Devices Reimbursement Market Size and Forecast, By Payer (USD Billion)

  • 5.1 Key payer trends
  • 5.2 Public
  • 5.3 Private

Chapter 6 Medical Devices Reimbursement Market Size and Forecast, By Healthcare Setting (USD Billion)

  • 6.1 Key healthcare setting trends
  • 6.2 Hospitals
  • 6.3 Outpatient facilities
  • 6.4 Others

Chapter 7 Medical Devices Reimbursement Market Size and Forecast, By Region (USD Billion)

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Poland
    • 7.3.7 Sweden
    • 7.3.8 The Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Indonesia
    • 7.4.7 Philippines
    • 7.4.8 Vietnam
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Columbia
    • 7.5.5 Chile
    • 7.5.6 Peru
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Turkey
    • 7.6.5 Israel
    • 7.6.6 Iran

Chapter 8 Company Profiles

  • 8.1 CVS Health
  • 8.2 BNP Paribas
  • 8.3 Aviva
  • 8.4 Cigna
  • 8.5 United Health Group
  • 8.6 Allianz
  • 8.7 Aetna
  • 8.8 Humana Inc.
  • 8.9 WellCare Health Plans, Inc.
  • 8.10 Nippon Life Insurance Company
  • 8.11 Anthem Insurance Companies, Inc.

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by payer (2022)
  • TABLE 3 Market revenue, by healthcare setting (2022)
  • TABLE 4 Market revenue, by region (2022)
  • TABLE 5 Global medical devices reimbursement market, 2018 - 2024 (USD Billion)
  • TABLE 6 Global medical devices reimbursement market, 2025 - 2032 (USD Billion)
  • TABLE 7 Global medical devices reimbursement market, by region, 2018 - 2024 (USD Billion)
  • TABLE 8 Global medical devices reimbursement market, by region, 2025 - 2032 (USD Billion)
  • TABLE 9 Global medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 10 Global medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 11 Global medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 12 Global medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 13 Industry impact forces
  • TABLE 14 Public market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 15 Public market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 16 Private market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 17 Private market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 18 Hospitals market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 19 Hospitals market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 20 Outpatient facilities market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 21 Outpatient facilities market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 22 Others market estimates and forecast, 2018-2024 (USD Billion)
  • TABLE 23 Others market estimates and forecast, 2025-2032 (USD Billion)
  • TABLE 24 North America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 25 North America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 26 North America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 27 North America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 28 North America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 29 North America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 30 U.S. medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 31 U.S. medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 32 U.S. medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 33 U.S. medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 34 Canada medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 35 Canada medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 36 Canada medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 37 Canada medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 38 Europe medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 39 Europe medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 40 Europe medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 41 Europe medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 42 Europe medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 43 Europe medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 44 Germany medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 45 Germany medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 46 Germany medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 47 Germany medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 48 UK medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 49 UK medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 50 UK medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 51 UK medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 52 France medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 53 France medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 54 France medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 55 France medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 56 Spain medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 57 Spain medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 58 Spain medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 59 Spain medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 60 Italy medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 61 Italy medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 62 Italy medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 63 Italy medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 64 Poland medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 65 Poland medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 66 Poland medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 67 Poland medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 68 Sweden medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 69 Sweden medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 70 Sweden medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 71 Sweden medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 72 The Netherlands medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 73 The Netherlands medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 74 The Netherlands medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 75 The Netherlands medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 76 Asia Pacific medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 77 Asia Pacific medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 78 Asia Pacific medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 79 Asia Pacific medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 80 Asia Pacific medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 81 Asia Pacific medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 82 China medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 83 China medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 84 China medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 85 China medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 86 Japan medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 87 Japan medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 88 Japan medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 89 Japan medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 90 India medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 91 India medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 92 India medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 93 India medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 94 Australia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 95 Australia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 96 Australia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 97 Australia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 98 South Korea medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 99 South Korea medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 100 South Korea medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 101 South Korea medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 102 Indonesia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 103 Indonesia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 104 Indonesia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 105 Indonesia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 106 Philippines medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 107 Philippines medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 108 Philippines medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 109 Philippines medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 110 Vietnam medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 111 Vietnam medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 112 Vietnam medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 113 Vietnam medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 114 Latin America medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 115 Latin America medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 116 Latin America medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 117 Latin America medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 118 Latin America medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 119 Latin America medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 120 Brazil medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 121 Brazil medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 122 Brazil medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 123 Brazil medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 124 Mexico medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 125 Mexico medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 126 Mexico medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 127 Mexico medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 128 Argentina medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 129 Argentina medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 130 Argentina medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 131 Argentina medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 132 Columbia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 133 Columbia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 134 Columbia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 135 Columbia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 136 Peru medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 137 Peru medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 138 Peru medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 139 Peru medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 140 Chile medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 141 Chile medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 142 Chile medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 143 Chile medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 144 MEA medical devices reimbursement market, by country, 2018 - 2024 (USD Billion)
  • TABLE 145 MEA medical devices reimbursement market, by country, 2025 - 2032 (USD Billion)
  • TABLE 146 MEA medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 147 MEA medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 148 MEA medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 149 MEA medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 150 South Africa medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 151 South Africa medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 152 South Africa medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 153 South Africa medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 154 Saudi Arabia medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 155 Saudi Arabia medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 156 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 157 Saudi Arabia medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 158 UAE medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 159 UAE medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 160 UAE medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 161 UAE medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 162 Turkey medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 163 Turkey medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 164 Turkey medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 165 Turkey medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 166 Israel medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 167 Israel medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 168 Israel medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 169 Israel medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)
  • TABLE 170 Iran medical devices reimbursement market, by payer, 2018 - 2024 (USD Billion)
  • TABLE 171 Iran medical devices reimbursement market, by payer, 2025 - 2032 (USD Billion)
  • TABLE 172 Iran medical devices reimbursement market, by healthcare setting, 2018 - 2024 (USD Billion)
  • TABLE 173 Iran medical devices reimbursement market, by healthcare setting, 2025 - 2032 (USD Billion)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Medical devices reimbursement industry 360 degree synopsis, 2018 - 2032
  • FIG. 7 Industry landscape, 2018 - 2032 (USD Billion)
  • FIG. 8 Growth potential analysis, by payer
  • FIG. 9 Growth potential analysis, by healthcare setting
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company matrix analysis, 2022
  • FIG. 13 Competitive positioning matrix
  • FIG. 14 Vendor matrix analysis
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 Strategy dashboard, 2022